Top 10 research priorities in inflammatory bowel disease in Australia: findings using the James Lind Alliance approach

Abstract Crohn's disease and ulcerative colitis affect 180 000 people in Australia, have no cure, have variable responses to treatment and cause a large burden of disease. Using methods developed by the James Lind Alliance, the top 10 research priorities were identified by consumers and clinicians to facilitate the planning and funding of future research.